SCHEMBL6916233

SCHEMBL6916233

C=CCc1nc(S)c2ccccc2n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.38
▸ KDM4E B2RXH2 4/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ KMT2A Q03164 6/20 0.35
▸ MEN1 O00255 5/20 0.35
▸ GAA P10253 3/20 0.35
▸ HTT P42858 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HPGD P15428 3/20 0.34
▸ MAOA P21397 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ GLA P06280 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ CHRM2 P08172 1/20 0.34
▸ ADRA2A P08913 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ CHRM1 P11229 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002095 0.79 DCPS (0.52) TDP1KDM4EALDH1A1RAB9ALMNA
SCHEMBL28412777 0.79 TDP1 (0.50) TDP1KDM4EALDH1A1RAB9AL3MBTL1
SCHEMBL31391444 0.77 ALDH1A1 (0.47) TDP1KDM4EALDH1A1L3MBTL1LMNA
SCHEMBL25746272 0.77 ALDH1A1 (0.47) TDP1KDM4EALDH1A1L3MBTL1LMNA
SCHEMBL10548915 0.74 ALDH1A1 (0.55) KDM4EALDH1A1L3MBTL1LMNAKMT2A
SCHEMBL31391515 0.72 POLB (0.43) KDM4EALDH1A1L3MBTL1LMNAKMT2A
SCHEMBL25746301 0.72 POLB (0.43) KDM4EALDH1A1L3MBTL1LMNAKMT2A
SCHEMBL15882934 0.72 KDM4E (0.37) TDP1KDM4EALDH1A1RAB9AL3MBTL1
SCHEMBL9273537 0.72 KDM4E (0.52) TDP1KDM4EALDH1A1RAB9ALMNA
SCHEMBL460158 0.71 TSHR (0.58) TDP1KDM4EALDH1A1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259192-A1 Method for cleaving the human growth hormone gh IBFB GMBH PRIVATES INSTITUT FUR BIOMEDIZINISCHE FORSCHUNG UND BERATUNG (DE) 2004-12-23 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259192-A1 Method for cleaving the human growth hormone gh MMP3, MMP25, MMP17 TDP1 3258/4885KDM4E 3443/4885ALDH1A1 3457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback